Author
J. Z. Xiang
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 44 mutual co-author links7 papers
Recent·Most cited
- Cell BiologybioRxivPreprint
Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing
T. Itkin, S. Houghton, R. Schreiner…·S. Rafii
The paper identifies Fli-1's role in regulating HSC activation during regenerative hematopoiesis by enabling niche signaling and functional recovery.
- ImmunologybioRxivPreprint
Innate-adaptive IFN cross-talk reprograms myeloid and T cells for antitumor immunity with a second-generation recombinant MVA
S. Liu, Y. Wang, G. Mazo…·L. Deng
This paper describes a second-generation recombinant MVA vaccine that enhances antitumor immunity by reprogramming myeloid and T cells through innate-adaptive IFN cross-talk.
- ImmunologybioRxivPreprint
Adaptive Immune Landscape of T-Cell Mediated Rejection of Human Kidney Allografts
F. B. Mueller, H. Yang, C. Li…·T. Muthukumar
This study analyzes the adaptive immune landscape of T-cell mediated rejection in human kidney allografts using RNA sequencing and identifies key molecular features associated with rejection.
DOI 10.1101/2022.05.15.492021 - DOI 10.1101/2021.10.31.466698
- MicrobiologybioRxivPreprint
Vaccinia E5 is a major inhibitor of the DNA sensor cGAS
N. Yang, Y. Wang, P. Dai…·L. Deng
This study identifies Vaccinia E5 as a major inhibitor of the cGAS-STING pathway by promoting cGAS degradation through proteasome-dependent ubiquitination.
DOI 10.1101/2021.10.25.465197 - MicrobiologybioRxivPreprint
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids
X. Duan, Y. Han, L. Yang…·T. R. Evans
This study uses human pluripotent stem cell-derived colonic organoids to identify drugs that block SARS-CoV-2 infection, finding mycophenolic acid and quinacrine dihydrochloride effective in vitro and in vivo.